These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23732777)

  • 41. NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma.
    Macheiner D; Heller G; Kappel S; Bichler C; Stättner S; Ziegler B; Kandioler D; Wrba F; Schulte-Hermann R; Zöchbauer-Müller S; Grasl-Kraupp B
    J Hepatol; 2006 Jul; 45(1):81-9. PubMed ID: 16516329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative methylation analysis of multiple genes using methylation-sensitive restriction enzyme-based quantitative PCR for the detection of hepatocellular carcinoma.
    Hua D; Hu Y; Wu YY; Cheng ZH; Yu J; Du X; Huang ZH
    Exp Mol Pathol; 2011 Aug; 91(1):455-60. PubMed ID: 21600201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Relationship between TIMP-3 expression and promoter methylation of TIMP-3 gene in hepatocellular carcinoma].
    Lü GL; Wen JM; Xu JM; Zhang M; Xu RB; Tian BL
    Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):230-3. PubMed ID: 12882688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
    Li B; Liu W; Wang L; Li M; Wang J; Huang L; Huang P; Yuan Y
    Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection.
    Narimatsu T; Tamori A; Koh N; Kubo S; Hirohashi K; Yano Y; Arakawa T; Otani S; Nishiguchi S
    Intervirology; 2004; 47(1):26-31. PubMed ID: 15044833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Promoter methylation of E-cadherin in hepatocellular carcinomas and dysplastic nodules.
    Kwon GY; Yoo BC; Koh KC; Cho JW; Park WS; Park CK
    J Korean Med Sci; 2005 Apr; 20(2):242-7. PubMed ID: 15831995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma.
    Li X; Hui AM; Sun L; Hasegawa K; Torzilli G; Minagawa M; Takayama T; Makuuchi M
    Clin Cancer Res; 2004 Nov; 10(22):7484-9. PubMed ID: 15569978
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequent methylation of Vimentin in well-differentiated gastric carcinoma.
    Kitamura YH; Shirahata A; Sakata M; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2009 Jun; 29(6):2227-9. PubMed ID: 19528485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequent k- ras -2 mutations and p16(INK4A)methylation in hepatocellular carcinomas in workers exposed to vinyl chloride.
    Weihrauch M; Benicke M; Lehnert G; Wittekind C; Wrbitzky R; Tannapfel A
    Br J Cancer; 2001 Apr; 84(7):982-9. PubMed ID: 11286481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.
    Jia HL; Ye QH; Qin LX; Budhu A; Forgues M; Chen Y; Liu YK; Sun HC; Wang L; Lu HZ; Shen F; Tang ZY; Wang XW
    Clin Cancer Res; 2007 Feb; 13(4):1133-9. PubMed ID: 17317821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vimentin methylation as a marker for advanced colorectal carcinoma.
    Shirahata A; Sakata M; Sakuraba K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2009 Jan; 29(1):279-81. PubMed ID: 19331162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Demethylation of the CD133 gene is frequently detected in early gastric carcinoma.
    Hibi K; Sakata M; Kitamura YH; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2010 Apr; 30(4):1201-3. PubMed ID: 20530428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.
    Ko FC; Yeung YS; Wong CM; Chan LK; Poon RT; Ng IO; Yam JW
    Liver Int; 2010 Jan; 30(1):139-48. PubMed ID: 19874489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma.
    Qiu GH; Xie H; Wheelhouse N; Harrison D; Chen GG; Salto-Tellez M; Lai P; Ross JA; Hooi SC
    J Hepatol; 2007 Apr; 46(4):655-63. PubMed ID: 17258345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma.
    Kondo Y; Kanai Y; Sakamoto M; Mizokami M; Ueda R; Hirohashi S
    Hepatology; 2000 Nov; 32(5):970-9. PubMed ID: 11050047
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.
    Schagdarsurengin U; Wilkens L; Steinemann D; Flemming P; Kreipe HH; Pfeifer GP; Schlegelberger B; Dammann R
    Oncogene; 2003 Mar; 22(12):1866-71. PubMed ID: 12660822
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of TFPI2 methylation in the serum of gastric cancer patients.
    Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2011 Nov; 31(11):3835-8. PubMed ID: 22110206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
    Iwata N; Yamamoto H; Sasaki S; Itoh F; Suzuki H; Kikuchi T; Kaneto H; Iku S; Ozeki I; Karino Y; Satoh T; Toyota J; Satoh M; Endo T; Imai K
    Oncogene; 2000 Nov; 19(46):5298-302. PubMed ID: 11077447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.